Crossmark

Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease

Crossref DOI link: https://doi.org/10.1038/s41420-025-02312-3

Published Online: 2025-02-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Yihuai

Jiang, Jinlian

Ou, Lili

Chen, Yunfen

Abudukeremu, Aikedaimu

Chen, Guimei

Zhong, Weiwei

Jiang, Zhigang

Nuermaimaiti, Nuerbiye

Guan, Yaqun https://orcid.org/0000-0002-5729-9889
License Information

Text and Data Mining valid from 2025-02-05

Version of Record valid from 2025-02-05
More Information

Article History

Received: 3 November 2023

Revised: 25 December 2024

Accepted: 21 January 2025

First Online: 5 February 2025

Competing interests

: The authors declare no competing interests.

: The experimental protocol was approved by the Zunyi Medical University Medical Ethics Review Committee, application numbers ZMER [2023]1-172 for cell experiments, and ZMU21-2107-003 and ZMU22-2303-029 for animal experiments. All methods were performed in accordance with the relevant guidelines and regulations.

: Not applicable.

Document is current

Any future updates will be listed below